Previously treated Chronic Lymphocytic Leukemia (CLL)
Showing 51 - 75 of >10,000
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- High Dose Methylprednisolone (HDMP)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Venetoclax
- +2 more
-
Nagoya-shi, Aichi, Japan
- +19 more
Jan 25, 2023
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)
Not yet recruiting
- Autoimmune Hemolytic Anemia
- +3 more
- Ibrutinib 420 mg
- (no location specified)
Jan 12, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Phoenix, Arizona
- +116 more
Jun 27, 2022
Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Observation
- (no location specified)
Oct 12, 2023
Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)
Completed
- Hepatitis
- Safety and Tolerability
- HEPLISAV-B
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2022
Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
MEOI and HRQoL in CLL Patients Treated With BTKis
Recruiting
- Chronic Lymphocytic Leukemia
-
Fountain Valley, California
- +15 more
Jan 16, 2023
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)
Recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Rituximab
- Zanubrutinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Whittier, CaliforniaInnovative Clinical Research Institute
Aug 8, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 2, 2022
B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Manhasset, New YorkFeinstein Institute for Medical research
Jul 6, 2022
Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
- Imbruvica Oral Product
-
Milano, MI, ItalyOspedale San Raffaele
Apr 2, 2022
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Be'er Sheva, HaDarom, Israel
- +12 more
Sep 9, 2022
SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- Electronic Health Record Review
-
Duarte, California
- +10 more
Jan 12, 2023
Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic
Completed
- CLL
-
Tampere, FinlandTampere university Hospital
Feb 22, 2022
Obinutuzumab in Follicular Lymphoma or Previously Untreated
Recruiting
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
- obinutuzumab
-
Busan, Korea, Republic of
- +16 more
Jul 1, 2022
Chronic Lymphocytic Leukemia Trial in Spain (Ibrutinib 140 MG Oral Capsule [Imbruvica])
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Ibrutinib 140 MG Oral Capsule [Imbruvica]
-
Palma De Mallorca, Illes Balears, Spain
- +19 more
Sep 15, 2022
Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
-
Huntsville, Alabama
- +87 more
Apr 25, 2022
Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
- BNC105P
- Ibrutinib
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 3, 2023
Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Oral Venetoclax Tablets in Combination With Intravenous
Terminated
- Chronic Lymphocytic Leukemia (CLL)
-
Moscow, Moskva, Russian Federation
- +3 more
Nov 18, 2021
Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)
Recruiting
- Chronic Lymphocytic Leukemia
- [U-13C]glucose
- [13C5]glutamine
-
Madison, WisconsinUniversity of Wisconsin
Jun 15, 2022
Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Leukemia
- Ibrutinib
- +3 more
-
Coral Gables, Florida
- +8 more
Sep 28, 2022